國立虎尾科技大學 |

Pharmacotherapy in Aortic Disease

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Pharmacotherapy in Aortic Disease/ edited by Arturo Evangelista, Christoph A. Nienaber.
其他作者:	Evangelista, Arturo.
面頁冊數:	XII, 269 p. 31 illus., 23 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cardiology. -
電子資源:	https://doi.org/10.1007/978-3-319-09555-4
ISBN:	9783319095554

Pharmacotherapy in Aortic Disease
Pharmacotherapy in Aortic Disease[electronic resource] /edited by Arturo Evangelista, Christoph A. Nienaber. - 1st ed. 2015. - XII, 269 p. 31 illus., 23 illus. in color.online resource. - Current Cardiovascular Therapy ;7. - Current Cardiovascular Therapy ;7.

Aortic atherosclerosis as an embolic source -- Aortitis -- Aortic aneurysm -- Marfan Syndrome -- Acute Aortic Syndrome -- Chronic aortic dissection.

This book is driven by the considerable progress made by novel imaging techniques in understanding the pathophysiology and evolution of aortic disease and its diagnosis. Despite the lack of symptoms in stable conditions, most aortic diseases have a high morbidity and mortality. New therapeutic strategies such as endovascular treatment and surgical techniques have appeared to improve conventional surgery in advanced phases of the disease, but until recently, medical treatment has focused on the control of cardiovascular risk factors using beta-blockers to reduce aortic wall stress by reducing blood pressure and heart rate. Pharmacotherapy in Aortic Disease updates the reader on the new medical treatment that are changing the natural history of these diseases. Leading experts have created a critical in-depth, yet concise, analysis of the available medical treatments for different aortic disease entities. Both basic research studies and clinical trials discussed in this book serve as a base for improving therapeutic management, delaying the need for surgery, and prolonging survival in these patients.

ISBN: 9783319095554

Standard No.: 10.1007/978-3-319-09555-4doiSubjects--Topical Terms:

593957
Cardiology.

LC Class. No.: RC681-688.2

Dewey Class. No.: 616.12

Pharmacotherapy in Aortic Disease
LDR:02609nam a22003975i 4500 001 960737
003 DE-He213
005 20200703023513.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319095554 $9 978-3-319-09555-4
024 7 $a 10.1007/978-3-319-09555-4 $2 doi
035 $a 978-3-319-09555-4
050 4 $a RC681-688.2
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 616.12 $2 23
245 1 0 $a Pharmacotherapy in Aortic Disease $h [electronic resource] / $c edited by Arturo Evangelista, Christoph A. Nienaber.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a XII, 269 p. 31 illus., 23 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Current Cardiovascular Therapy ; $v 7
505 0 $a Aortic atherosclerosis as an embolic source -- Aortitis -- Aortic aneurysm -- Marfan Syndrome -- Acute Aortic Syndrome -- Chronic aortic dissection.
520 $a This book is driven by the considerable progress made by novel imaging techniques in understanding the pathophysiology and evolution of aortic disease and its diagnosis. Despite the lack of symptoms in stable conditions, most aortic diseases have a high morbidity and mortality. New therapeutic strategies such as endovascular treatment and surgical techniques have appeared to improve conventional surgery in advanced phases of the disease, but until recently, medical treatment has focused on the control of cardiovascular risk factors using beta-blockers to reduce aortic wall stress by reducing blood pressure and heart rate. Pharmacotherapy in Aortic Disease updates the reader on the new medical treatment that are changing the natural history of these diseases. Leading experts have created a critical in-depth, yet concise, analysis of the available medical treatments for different aortic disease entities. Both basic research studies and clinical trials discussed in this book serve as a base for improving therapeutic management, delaying the need for surgery, and prolonging survival in these patients.
650 0 $a Cardiology. $3 593957
650 0 $a Pharmacotherapy. $3 973587
650 0 $a Cardiac surgery. $3 1254013
650 2 4 $a Cardiac Surgery. $3 673715
700 1 $a Evangelista, Arturo. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1064619
700 1 $a Nienaber, Christoph A. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1064620
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319095547
776 0 8 $i Printed edition: $z 9783319095561
830 0 $a Current Cardiovascular Therapy ; $v 7 $3 1254793
856 4 0 $u https://doi.org/10.1007/978-3-319-09555-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)